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Abstract: The presented research aims to verify whether physicochem ical properties of lung fibroblasts, 
m odified by substrate stiffness, can be used to discrim inate betw een norm al and fibrotic cells from 
idiopathic pulm onary fibrosis (IPF). The im pact of polydim ethylsiloxane (PDMS) substrate stiffness 
on the physicochem ical properties of norm al (LL24) and IPF-derived lung fibroblasts (LL97A ) w as 
examined in detail. The growth and elasticity of cells were assessed using fluorescence m icroscopy and 
atomic force m icroscopy w orking in force spectroscopy m ode, respectively. The num ber of fibroblasts, 
as w ell as their shape and the arrangem ent, strongly depends on the m echanical properties of the 
substrate. Moreover, normal fibroblasts remain more rigid as compared to their fibrotic counterparts, 
w hich  m ay indicate the im pairm ents of IPF-derived fibroblasts induced by the fibrosis process. 
The chem ical properties of n orm al and IPF-derived lung fibroblasts inspected u sing tim e-of-flight 
secondary ion mass spectrometry, and analyzed com plexly w ith principal component analysis (PCA), 
show  a significant difference in the distribution of cholesterol and phospholipids. Based on the 
observed distinctions betw een healthy and fibrotic cells, the m echanical properties of cells m ay 
serve as prospective d iagnostic biom arkers enabling fast and reliable identification of idiopathic 
pulm onary fibrosis (IPF).
Keyw ords: idiopathic pulm onary fibrosis; fibroblasts; substrate elasticity; force spectroscopy
1. Introduction
Interstitial lung diseases (ILD) form a heterogeneous group of disorders w ith varying degrees of 
inflam m ation and fibrosis, affecting m ainly the interstitium  of the lungs (the tissue and space between 
the epithelial and endothelial basem ent m em branes) [1 ,2] . Though ILD  m ay be caused by some specific 
factors such as connective tissue diseases, diseases w ith granulom a formation, organic dust, or certain 
drugs, in the m ajority of cases, no obvious cause can be identified [3 ]. One of the m ost frequent forms 
of ILDs is idiopathic pulm onary fibrosis (IPF) [4- 7].
N ow adays, the d iagnostic process is based on a m ultid iscip linary approach involving 
pulm onologist, radiologist and pathologist experts and sophisticated exam ination techniques, such as
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high-resolution com puted tom ography (HRCT), and in some cases lung biopsy [7- 10], which makes it 
long, expensive and, unfortunately, still not always reliable.
M aking the proper diagnosis of IPF is hard. There are almost 200 different ILDs, and in most cases, 
their clinical m anifestations are very sim ilar if not the same. Additionally, there are a lot of similarities 
and overlap of the radiologic and histopathological patterns, which makes diagnosis even more difficult. 
In the year 2018, a m ultid iscip linary com m ittee of IPF experts from  the A m erican Thoracic Society, 
European R espiratory Society, Japanese R espiratory Society, and Latin A m erican Thoracic Society 
provided 'A n Official ATS/ERS/JRS/ALAT C linical Practice G uideline' form ulating recom m endations 
related to the d iagnosis of IPF [11]. H ow ever, even w ith  the proposed interdisciplinary approach, 
significant disagreement in diagnosed disease exists w ithin physicians, especially between community- 
and academ ic-based  ones; therefore, the d iagnosis of an  individual patient can significantly differ 
depending on the physician  and, particularly, the location of the evaluation. M oreover, in  clinical 
practice, m ultid iscip linary experts rarely w ork  together and usually  the pulm onary physician is 
responsible for integration and analysis of all the gathered clinical, radiographic, and pathologic data 
and final diagnosis of a given patient. Therefore, there is a constant need for an earlier, non-invasive 
and reliable diagnostic m ethods [12], crucial for effective therapies. A fast diagnosis enables the early 
treatm ent of IPF, w hich  is critical to preserving the patients ' lung function, reduce the risk of acute 
exacerbations, and im prove outcom es [12,13].
In  IPF, the changes in cell properties, together w ith  an  extensive deposition of collagen and 
other com ponents of the extracellular m atrix (ECM ), disrupt norm al lung architecture and functions. 
The progression of fibrosis and inflam m atory processes m ay lead to the developm ent of dyspnea, 
cough, and ultimately, in som e cases, respiratory failure and death [14]. A lthough the etiology of IPF 
rem ains poorly  defined, it is believed to be the result of repeated dam age to the alveolar epithelium  
and aberrant w ound healing processes in the pulm onary  interstitium  [15]. The progress of IPF 
m ight be associated w ith  an aberrant w ound healing  process in the pulm onary interstitium , due to 
fibroblast proliferation and the abnorm al accum ulation of EC M  [16- 18]. M oreover, the increased 
matrix stiffening observed in the lung fibrotic process may be a critical fibrogenesis driving factor [19] 
and the m yofibroblast differentiation can be induced in fibroblasts, m erely  by altering the stiffness 
of the u nderlying substrate [20]. In turn, the stiffening of single fibroblasts m ay affect the lungs at a 
tissue level, leading to the corruption of m echanically-derived signals that are typically  transm itted 
through the ECM  [21,22]. Normal pulm onary function and architecture of lungs may be influenced by 
the rapid, slow, or m ixed [2,23] progress of the disease, leading to an irreversible increase of stiffness, 
even up to 30-fold  [24- 26]. A  panel of IPF researchers gathered in 2014 by  the N ational H eart, Lung, 
and Blood Institute in the U nited States em phasized that the m echanism s of m atrix stiffening and 
influence of increased stiffness on cellular processes remain an im portant, open question in the field of 
IPF research [27].
A lot of effort is made in the development of the prognostic indicators of IPF [2,23]. The cytoskeleton 
organization, as w ell as the contractility of the lung fibroblast originating from IPF, has been reported 
to differ from  the norm al tissue [28,29]. This im plies that the m echanical properties of individual 
fibroblasts should be altered. Besides, the m echanical properties of the fibroblasts' environm ent seem 
to be an extrem ely im portant factor in cellular response, thus, this requires a deeper study of the effect 
of substrate stiffness on properties of lung fibroblasts towards establishing its role in the developm ent 
of IPF  lung im pairm ent. How ever, up to date, the research aim ed at this issue focuses m ainly on the 
elasticities typical for healthy and fibrotic lung fibroblasts, i.e., up to a few  tens of kPa [21,25,29- 31]. 
They show  the great im pact of stiffness on cellular behavior, but the underlying m echanism s are still 
not known. In turn, som e other research report that besides substrate stiffness, several other m aterial 
properties including the dam ping coefficient [32] and stress relaxation [33] of the substrates are of 
im portance, and should be considered in the m echanotransduction m echanism  [34].
In  our previous w ork  [35], w e have show n that the elasticity  of polydim ethylsiloxane (PD M S) 
substrates has an im pact on lung fibroblasts response affecting their properties and proliferation.
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Thus, w e assum e that these differences m ay be potentially  useful to d iscrim inate betw een healthy 
and fibrotic fibroblasts. To verify  this hypothesis, w e decided to expand the study and perform  
detailed tests of the im pact of substrate stiffness on physicochem ical properties of w ell-defined, 
com m ercially  available, im m ortalized cell lines of norm al and IPF-derived lung fibroblasts. In  the 
present paper, the proliferation and elastic m odulus of norm al and IPF lung fibroblasts w ere studied 
using fluorescence m icroscopy (MF) and atomic force m icroscopy (AFM) working in a force spectroscopy 
m ode, respectively. The proliferation of alive cells w as exam ined u sing M T S assay. To com pare 
the chem ical properties of norm al and IPF-derived lung fibroblasts, their chem ical com position w as 
inspected using tim e-of-flight secondary ion mass spectrom etry (ToF-SIMS), com bined w ith principal 
com ponent analysis (PCA), w hich allows one to detect subtle differences betw een the sam ples.
2. M aterials and M ethods
2.1. Preparation o fP D M S  Substrates
Sylgard 184 (D ow  C orning) w as used to prepare PD M S substrates. First, the elastom er base 
w as m ixed w ith  the curing agent (m ass ratio of 10:1). Then, to enable the ad justing of substrate 
elasticity, a solution of benzophenone (Sigm a-A ldrich, D arm stadt, G erm any) in  xylene (200 m g/m L, 
POCH Gliwice, Poland) was added to the mixture, at the mass ratio of 1:100 benzophenone:PDM S and 
degassed. The PD M S substrates w ere fabricated using a spin-coating technique (spinning speed 
500 rpm , KW -4A , C hem at Scientific, N orthridge, CA , U SA ) on a 25  m m  round coverslip  glass. 
To produce soft substrates, some sam ples were additionally irradiated for 5 h w ith UV light (A =  254 nm 
400 W  m ercury lam p). In the last step, substrates w ere baked for 15 m in at 150 °C  (M C S67 hot plate, 
CAT, Ballrechten-D ottingen, Germ any).
2.2. Cell Culture
H um an lung fibroblasts (norm al LL24, catalog num ber ATCC-CCL-151 and IPF-derived LL97A, 
catalog num ber A TCC-CCL-191 cells) w ere purchased from  ATCC (M anassas, VA, USA ). Cells w ere 
cultured in the F-12K  m edium  (ATCC, catalog  num ber 30-2004), w hich  w as supplem ented w ith  a 
15% fetal bovine serum (Sigma-Aldrich, Darmstadt, Germany, catalog number: F9665) and 1% antibiotic 
(Sigm a-A ldrich, D arm stadt, Germ any, catalog  num ber: P4083) in  culture flasks, in a C O 2  incubator 
providing 95% air/5% CO 2  atmosphere. The PDM S substrates w hich were attached to glass coverslips 
w ere placed into the bottom  of the Petri d ish (35 m m  in d iam eter) and they w ere sterilized for one 
hour under UVC light (germ icidal lam p, A =  254 nm) under a lam inar flow cham ber (Nu425, NuAire, 
Plym outh, M N , U SA ). A fter that, cells (80,000 cells per m l of the culture m edium ) w ere placed over 
the all type o f PD M S surface. N ext, the Petri dishes w ere incubated in  the C O 2  incubator by  1, 3, 
or 6  days. For each experimental sequence, two or three identical samples were prepared and m easured. 
A ll experim ents w ere repeated a t least three tim es for each cell line and a tim e-point to proving the 
reproducibility of the results.
2.3. Force Spectroscopy
C om m ercially  available A FM  system  (Bruker-JPK , Berlin , G erm any) equipped w ith  tw o heads 
C ellH esion or N anow izard 4  w as used to conduct force spectroscopy and quantitative im aging (QI), 
respectively. The PDM S substrates w ith cells were mounted in the AFM  liquid cell filled w ith a culture 
m edium  (F-12K medium). The commercially available silicon nitride AFM  probe (ORC8-10 D, Bruker) 
was im mersed into medium and brought close to the surface. Force curves (i.e., dependencies between 
a vertical deflection and scanner position) w ere collected w ith in  a grid of 4 X 4 points, form ing a 
5 pm X 5 pm elasticity map. Each map w as recorded for only one cell over the cellular nuclear region. 
In  total, at least 40 cells w ere m easured for each substrate and tim e point. To obtain the value of the 
relative Young's m odulus, an approach part of a recorded force curve w as analyzed. It w as converted 
into a force versus indentation curve to w hich the H ertz contact m odel w as fitted [36]. The shape of
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the probing tip w as approxim ated by a paraboloid. The Young m odulus w as calculated as a m ean 
±  standard deviation. To validate the statistical significance am ong various sam ples, the one-w ay 
ANOVA followed by Bonferroni's post hoc com parisons tests w ere used.
Local elasticity m aps of norm al and IPF-derived fibroblasts were recorded using the quantitative 
imaging (QI) capability of the Nanowizard 4 AFM head. These maps were recorded w ithin a scan area 
of 50 pm X 50 pm (256 X 256 pixels).
2.4. Time o f  Fight Secondary Ion M ass Spectrom etry (ToF-SIMS)
Im aging and m olecular characterization of norm al and IPF-derived fibroblasts w ere perform ed 
using TO F-SIM S 5 apparatus (IO N -TO F G m bH , M unster, G erm any). B i3  ion clusters generated by 
30 keV bism uth liquid metal ion gun were used as prim ary ions. The ion dose density w as kept below 
1 0 1 2  ion/cm 2  to ensure static mode conditions and a pulsed low-energy electron flood gun w as used for 
charge com pensation.
Firstly, high resolution m ass spectra (m/Am >  7000) w ere acquired from  at least 4 random ly 
chosen, non-overlapping spots (150 pm X 150 pm area). N ext, collected m ass spectra w ere analyzed 
using principal com ponent analysis (PCA ), to find alterations in surface chem ical properties am ong 
the studied LL24 and LL97A  cell lines. PC A  w as conducted using the PLS Toolbox (Eigenvector 
Research, M anson, W A, U SA ) for M A TLA B (M athW orks, Inc., N atick, M A , U SA ). Prior to PCA , 
the intensities of selected peaks from each spectrum were normalized to the sum of selected peaks and 
mean-centered. Finally, high-resolution im ages of both cell lines w ere collected in im agine mode from 
several non-overlapping 300 pm X 300 pm areas (with a resolution of 256 X 256 points).
2.5. Colorimetric M TS Assay
The viability of cells was verified using an M TS calorimetric test. Briefly, fibroblasts were cultured 
in a m ulti-w ell plate (24 w ells) in  1  m L of the corresponding culture m edium . N ext, 100 pL of M TS 
reagent (tetrazolium  com pound) w as added to the cells in the culture m edium . Then, cells w ere 
incubated at 37 °C in 95% air/5% CO 2  atmosphere, in the incubator (Nuaire) for 1 h. The M TS method 
is based on the reduction of tetrazolium  com pound by  viable cells to generate a colored form azan 
product that is soluble in cell culture media. The final volum e of 1.1 mL was pipetted to a 96-well plate 
w ith  100 pL per hole. The absorbance w as determ ined in the 96-w ell for each tim e spot of 24 h, 72 h, 
and 144 h a t O D  =  490 nm . The M TS assay w as repeated at least three tim es for each cell line and a 
tim e-point. For each experim ental run, tw o or three identical sam ples w ere prepared and measured.
2.6. Fluorescence Im aging
Before fluorescence staining of actin filam ents and the cell nucleus, cultured cells w ere pre-fixed 
to the substrate by adding a 1  mL solution of 3:7%  of paraform aldehyde (Fluka, Charlotte, NC, USA) to 
the culture m edium  for 2 min at 37 °C. Then, cells w ere w ashed w ith phosphate-buffered saline (PBS, 
Sigm a-Aldrich, Darm stadt, Germany) 3 times for 2 min. Afterwards, the sam ple w as im m ersed in the 
solution of 3.7%  of paraform aldehyde Fluka, C harlotte, N C, U SA ) for 15 m in at room  tem perature, 
to fix cells firmly. After fixation, coverslips w ith cells w ere rinsed tw ice w ith the PBS buffer for 2 min. 
After that, a cold solution (4 °C) of 0.2% Triton X-100 (Sigma-Aldrich, Darmstadt, Germany) was added 
for 4 m in, follow ed by w ashing coverslips w ith  the PBS buffer for 2 m in. N ext, cells w ere incubated 
w ith phalloidin conjugated with a 1:200 solution Alexa Fluor 488 dye (Invitrogen, Carlsbad, CA, USA) 
for 40 min, and subsequently, cell nuclei were incubated with a 1:5000 solution containing Hoechst dye 
(Sigma) for 14 min. The fluorescent images were collected from at least three repetitions carried out for 
each cell line and a tim e-point. For each experim ental run, at least 10 fluorescent im ages from two or 
three coverslips w ith stained cells w ere collected.
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3. Results
3.1. Fluorescence
To elaborate on how fibroblasts behave in a distinct mechanical environment, two PDM S substrates 
characterized by 600 kPa (referred to here as a soft PDM S substrate) and 1.5 M Pa (a stiff PDM S) w ere 
chosen. The spreading; of fibroblasts w as monitored by fluorescence im aging after 24h, 72 h and 144 h 
of culture (F ig u resi  and 2).
Figure 1. Normal lung fibroblasts (LL24) visualized by fluorescent microscopy by staining actin 
cytoskeleton (phalloidin—Alexa Fluor 488) an d cell nucleus (Hoechst). Cells cultured on soft 
(left column) and stiff (central column) polydimethylsiloxane (PDMS) were compared to cultures 
earried out on the glass Icontrol; right column). Cultures were conducted for 24h (a-c), 72h (d-f) and 
144h(g-i).
For stiff PD M S substrate (of 1.5 M Pa), instead of spreading, cells tend to aggregate and to form
agglom erates, w ith cells grow ing on each other, as show n in Figure 3 .
3.2. M TS
In our next step, we elaborate on how the elasticity of the PDM S substrates affects the proliferation 
of alive fibroblasts, corresponding to the viability of cells using an M TS assay applied at each time spot. 
The results are presented in Figure 4 for LL24 (a) and LL97A  (b) lung fibroblasts.
The M TS values show that the proliferation of healthy lung fibroblasts (Figure 4a) is significantly 
reduced on the stiffer substrate as com pared to the soft one. In contrast, for IPF-derived fibroblasts 
(Figure 4b ), no significant difference is revealed for cells cultured on stiff and soft PDMS. Both cell lines 
proliferate m ost effectively on control glass sam ples.
3.3. Elasticity
The Young m odulus of lung fibroblasts (Figure 5 ) w as determ ined using the A FM -based force 
spectroscopy [37] from  m easurem ents conducted for all culture tim es and both  PD M S substrates. 
In this technique, the analysis of the collected force curves w ith  H ertz contact m echanics provides 
Young m odulus as a characteristic property for a m aterial w ith given m echanical properties.
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Figure 2. Fluorescent images of idiopaithic pulmonary fibrosis (IPF)-derived lung; fibroblasts (LL97) 
visualized lay staining; actin cytoskeleton (phalloidin—Alexa Fluor 488) and cell nucleus (Hoechst). 
Cells cultured on soft (left column) and stiff (central column) PDMS were comp ared to cultures carried 
out on the glass (control; right column). Cell culture was conducted (right column) after incubation fcr 
24 (a-c), 72 (d-f) and 144h (g-i).
Figure 3. Agglomerates of healthy (LL24, a) and fibrotic (LL97A, b) lung fibroblasts after 72 h culture 
on stiff PDMS substrate.
The LL24 fibroblasts cultured on soft PD M S show ed a significantly increased Young m odulus 
after 72 and 144 h as compared to the stiff PDMS. These results differ noticeably from the observations 
m ade for tire LL9 7A  fit,robl asts. H ere, a significantly increased Young m odulus on the stiff PD M S is 
observed at early incubaOion timeo (24 h), an-  for longer culture tim es (72 h, 144 h), the stiffness of 
LL97A fibroblasts becom es com parable for both anafyzed substrates.
3.4. Elasticity M aps
In  addition to the m ean elasticity, the spatial d istribution of m echanical properties of cells w as 
also analyzed, by  recording the elasticity m aps of cell fragm ents (Figure 6 ) .
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Figure 4. Viability of LL24 (a) and LL97A (lb) cells cultured on soft and stiff PDMS substrates as 
well as oontrol glass sample after fibroblasts cuhure for 24, 72, fnd 144 h obtained using MTS assay 
(*significantly different from each othe), p <  0.01). Data are presented as a meon ± standfrd deviation 
(SD) from n =  6 repetitions.
Figure 5. Young modulus of LL24 (a) and LL9 7A (b) cells on soft (solid symbols) and stiff (open symbols) 
PDMS after incubation for 24, 71, and 144h (*significantly different from each other, p <  0.01) determined 
using; atomic force microscopy (AFM)-based force spectroscopy. Error bars ind icate the SD (n >  40).
A comparison of the elasticity maps recorded for a healthy LL24 cell line (Figure 6 b ) and IPF-derived 
LL97A one (Figure 6 d) show uslight didferences in the spatial distribution of their mechanical properties. 
For healthy fibroblasts, elasticity  is highly  heterogeneous, rather sm all for the central part of the cell 
w ith limited stiffer regions, locafed m ostly tit the edges od a csfl. In turn, maps recorded for IPF-derived 
fibroblasts show  a h ighly uniform  dirtribution  of elartic properties, w ith  stiffer areas arranned in 
characteristic fibers in the w hole area o l the tell.
3.5. ToF-SIMS
"The oossibility of d iscrim inationbetw eeo normal and fibrotic Obroblnsts based on aheir chemical 
com position was veaified using ToF-SIMS. Prior to tire m easurements, a drying protocol using multistep 
w ashing of cells in diluted solutions of anhydrous alcohol w as applied [38].
The representative m/z spectra, recorded for LL24 and LL97A cell (Figure 7) present sim ilar patterns 
of peaks, w ith  the sam e m /z positions and only slightly  varied intensities. Therefore, to provide 
a quantitative analysis o f even very  subtle differences in the chem ical com position of exam ined 
fibroblasts, a com plex PCA  analysis w as perform ed (Figure 8 ).
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Figure 6 . Topography (a,c) and elasticity maps of fibroblasts fragments (b,d) recorded for healthy 
(LL24, a,b) and IPF-derived ( (LL97A, c,d) fibroblasts recorded Ufing the quantitative imaging (QI) inode 
of AFM.
Figure 7. Characteristic spectra recorded for LL24 (blue line) and LL97A (red line) cells using 
time-of-flight secondary? ion mass spectrometry (ToF-SIMS).
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Figure 8 . PCA scores plot of1 LL24 and LL97A cell lines (a) and corresponding loadings plot for 
PC1 tvith peaks named (black), with the highest differences in intensity and (red) foagments of 
phosphatidylcholine (b).
As seen in Figure 8 a, the first principal com ponent (PC1) show s the greatest variation (89.95% ) 
betw een spectra collected for LL24 (negative scores) and LL97A  (positive ecores) cell lines. Based on 
the loadings plot (Figure 8 b ), it cen be seen that the positive scores on PC1 are related w ith secondary 
ions, w i)h  m/z =  147.1 and m/z =  184.1 (C 5 H 1 5 N PO 4 +) identified as a m ajor cholesterol [39] and 
phosphatidylcholm e [40] fragm ents, respectively. M oreover, closer m spection of loadings plots also 
revealed three other fragm ents im /z =  104.11, C 5 H 1 4 N O +; m /z =  125.0, C 2 H 6 PO 4 + ; m /z =  224.13, 
C 8 H 1 9 N PO 4 + ), of phosphatidylcholine, w hich loaded PC1 positively.
Finally, the spatial distribution of cholesterol (m/z =  147) and phospholipids (m/z =  184) in cells 
were traced on com position maps, also provided by ToF-SIMS technique (Figure 9), showing a significant 
difference in Che distribution of both species recorded for healthy (upper row) and IPF-derived (bottom 
row) fibroblasts.
Figure 9. Composition maps corresponding to the total cell area (m/z = 43, a,d), cholesterol (m/z =  147, 
b,e) and phospholipids (m/z = 184:, c,f) recorded for LL24 (upper row) and LL97A (bottom row) cell line.
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4. D iscussion
O ur study aimed to verify w hether the physicochem ical properties of lung fibroblasts, modified by 
substrate elasticity, can be used to discrim inate betw een norm al and fibrotic cells.
4.1. Fluorescence
The stiffness of the substrate is know n to im pact adhesion and proliferation of cells [41- 47]. 
O ur previous research, perform ed for PD M S elasticity  changing stepw ise from  600 kPa to 1.5 M Pa, 
showed that substrate stiffness affects the behavior of normal and IPF-derived fibroblasts, influencing the 
number, shape, and arrangem ent of cells after 72 h culturing [35]. To elaborate on how fibroblasts behave 
in a d istinct m echanical environm ent, tw o PD M S substrates characterized by  600 kPa (referred here 
as a soft PD M S substrate) and 1.5 M Pa (a stiff PD M S) w ere chosen. The surfaces of these PD M S 
substrates w ere not m odified w ith  any EC M  proteins. The adhesion of fibroblasts to bare PD M S 
surface proceeds through serum proteins, such as arginine-glycine-aspartic acid sequence (RGD, [48]) 
from  the culture m edium , w hich  provides an adhesion m atrix for cells, enhancing their capacity  to 
in teract and spread [49]. The spreading of fibroblasts w as m onitored by fluorescence im aging after 
24 h, 72 h and 144 h of culture (Figures 1 and 2).
O n soft P D M S substrate (600 kPa), norm al (LL24, Figure 1), as w ell as IPF-derived (LL97A , 
Figure 2 ), lung fibroblasts grow  and proliferate sim ilarly to the fibroblasts culture on a control glass 
sample. Their growth reaches a state of a confluent m onolayer already after 72 h. Cells are flat, w ith a 
spindle-like shape, w hich is typical for fibroblasts.
In turn, on the stiff PDMS substrate (of 1.5 M Pa), instead of spreading, cells tend to aggregate and 
to form agglomerates, w ith cells growing on each other, as shown in Figure 3 . A similar arrangement of 
fibroblasts w as reported for cells cultured in adverse environments, where the cell-cell interactions are 
favored over cell-substrate ones [50- 53]. A lthough the aggregation of cells m ay affect their biological 
functions [50- 53], it is irrelevant for our goal, i.e., the discrim ination betw een norm al and fibrotic 
lung fibroblasts.
4.2. M TS
For healthy lung fibroblasts, the M TS tests show  that the num ber of norm al cells is reduced 
on the stiffer substrate. In contrast, for IPF-derived fibroblasts, the M TS analysis does not reveal 
any significant difference betw een the num ber of IPF-derived cells cultured on stiff and soft PD M S, 
concluded for fluorescence m icrographs, indicating that substrate elasticity  affects the arrangem ent 
of fibrotic cells rather than their ability  to proliferate. The observed different response of both  cell 
types to the substrate stiffness suggests that the internal structure of cells, m odified for fibroblasts for 
ILD disorders, as w ell as the postulated alteration of their mechanical properties [28,29], influence the 
cellular behavior and adaptability  to the external conditions and m ight be an im portant factor in 
enabling discrim ination betw een healthy and norm al cells.
4.3. Elasticity
The cytoskeleton organization, as well as the contractility of lung fibroblasts originating from IPF, 
differs from  the norm al lung tissue [28]. Know ing that alterations in  actin filam ents can be related to 
alterations in the mechanical properties of cells measured by AFM [54- 56], the Young m odulus of lung 
fibroblasts w as determ ined using AFM -based force spectroscopy [37]
For both  cell lines, an increase of Young's m odulus w ith  tim e is observed, especially  for cells 
cultured on softer PD M S substrate. H ere, elasticity  m odulus doubles for norm al fibroblasts and 
becom es four tim es larger after 144 h of incubation for IPF-derived ones. This effect m ay be related 
to the presence of neighboring cells, w hich  affects Young's m odulus even for A FM  m easurem ents 
carried out on  individual cells. The recorded m oduli im ply that norm al fibroblasts rem ain m ore 
rigid as com pared to their fibrotic counterparts. O bserved difference m ay indicate the im pairm ents
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of IPF-derived fibroblasts induced by  the fibrosis process, bu t it can be also linked w ith  the donor 
age, different for both cell lines. To resolve this issue, extended studies for patient-derived fibroblasts 
are required.
O bserved values of m oduli are m uch higher than the physiological range of the Young m odulus 
of pulm onary tissue (~ 2 -1 0  kPa) reported elsew here [24,25,57,58]. M oreover, the observed tendency 
in cell stiffness is opposite to the one reported before— the healthy fibroblasts are stiffer than the 
IPF-derived ones. These results are not intuitive, however, IPF-derived fibroblasts differ in im portant 
aspects from normal lung tissue-derived fibroblasts, raising the possibility that IPF-derived fibroblasts, 
like som e cancer cell lines, m ay lose their responsiveness to m atrix stiffness [29].
4.4. E lasticity M aps
The m echanical properties of cells are substantially different for the cellular m em brane and the 
subcellular com ponents, such as the cytoskeleton or nucleus [59]. The m em brane is m uch softer than 
other com ponents and m echanical stability is provided by  the cytoskeleton, w hich  is also actively 
involved in the application of forces onto cell-cell and cell-extracellu lar m atrix interactions [60]. 
Therefore, in addition to the m ean elasticity, the spatial distribution of m echanical properties of cells 
w as also analyzed, by recording the elasticity m aps of cell fragm ents (Figure 6 ) .
The observed slight differences in elastic properties betw een norm al and IPF-derived fibroblasts, 
corresponding to the internal arrangem ent of the cytoskeleton, may influence the mechanical properties 
of the exam ined cells, w hich m ay be therefore considered as potential diagnostic m arkers.
4.5. ToF-SIMS
Inflam m atory lung diseases are know n to affect the biochem ical properties of the tissue. 
Several reports suggest the critical im portance of lipoproteins and cholesterol for norm al lung 
physiology [61], how ever, the detailed u nderlying m echanism s of this effect rem ain unclear [61,62]. 
M ost probably, it is related to the perturbations in biochem ical hom eostasis o f the pulm onary 
surfactant [63], w hich consists of approxim ately 90% lipids and 10% proteins, and plays an im portant 
role in maintaining normal respiratory mechanics [64]. Moreover, an aberrant deposition of extracellular 
m atrix (ECM ) constituents, such as g lycosam inoglycans, is characteristic of IPF [65]. Furtherm ore, 
diffuse pulm onary ossification (D PO ), i.e., calcification in  a collagen m atrix leading to bone tissue 
formation, in the lung parenchyma is common in patients w ith fibrosing ILD, especially with IPF [66,67].
Taking into account the biochem ical changes occurring at the cell surface, w e test the possibility 
of discrim ination betw een norm al and fibrotic fibroblasts, based on their chem ical com position using 
ToF-SIMS. The representative m/z spectra, recorded for LL24 and LL97A cell (Figure 7), present similar 
patterns of peaks, w ith  the sam e m /z positions and only slightly varied intensities. Therefore, 
to provide a quantitative analysis of even very  subtle differences in the chem ical com position of 
exam ined fibroblasts, a com plex PCA analysis w as perform ed.
In  turn, ToF-SIM S analysis does not show  any difference in the intensities of Ca (m/z =  39.96) 
and C aO  (m /z =  56.96) peaks recorded for both  cell lines, indicating a sim ilar am ount of C a for them  
(Supporting Inform ation, Figure S1), w hich  is in  accordance w ith  the glycosam inoglycans and Ca 
staining (Supporting Inform ation, Figure S2). The surface coverage is comparable for both cell lines and 
equals to 0.69 ±  0.07 and 0.61 ±  0.05 for healthy and IPF-derived fibroblasts, respectively (cf. Figure 8 a,d), 
therefore, the potential contribution of m edia com ponents, such as choline, inositol or glutam ine to 
the observed difference is m inim ized. M oreover, the obtained result is consistent w ith literature data, 
indicating that IPF disorder is associated w ith the disturbance in the biosynthesis and m etabolism  of 
cholesterol [62]. Furtherm ore, the intensity  of signals characteristic for phosphatidylcholine [68,69] 
points to a higher am ount of phospholipids for IPF-derived fibroblasts. This effect is intuitive, 
as oxidized phospholipids are know n to influence inflam m atory processes [70] and to be highly 
abundant in the pulm onary surfactant lipid system , disturbed for ILD diseases [62- 64,69].
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Finally, the spatial distribution of cholesterol (m/z =  147) and phospholipids (m/z =  184) in cells 
w as traced on com position m aps, also provided by  ToF-SIM S technique (Figure 9 ).
Figure 9a ,d show  substrate coverage by  norm al and IPF-derived fibroblasts, respectively. 
Fibroblasts are visualized here by m/z =  43 signal, present for both cell lines, and not contributing to their 
differentiation in PCA analysis (Figure 8 b ). The com parison of m aps tracing cholesterol (Figure 9b ,e) 
and phospholipids (Figure 9c,f) show s a significant difference in the distribution of both  species 
recorded for healthy (upper row) and IPF-derived (bottom row) fibroblasts. First of all, their amount is 
noticeably low er for healthy cells and secondly, their location is changed. For IPF-derived fibroblasts, 
cholesterol and phospholipids are d istributed hom ogeneously in the w hole cell area, w hereas for 
healthy ones, they accumulate on the edge of the cell. The potential contribution of media components, 
such as choline and inositol, being  precursors of phospholipids [71] (m/z =  184) or glutam ine to 
m/z =  147 [72] can be neglected, as the recorded differences in their intensities correspond only to the 
cell area and remain constant for the substrate not covered w ith fibroblasts. Based on com position maps 
recorded using ToF-SIM S and elasticity  m aps, exam ined using A FM , no direct relationship betw een 
the chem ical com position of cells and their m echanical properties m ay be concluded. The different 
distribution of cholesterol and phospholipids seem s not to be crucial for either the overall mechanical 
properties of the cell or their spatial distribution. These results, although not intuitive, are in agreement 
w ith literature data w hen the stiffening of cells is observed for cholesterol depletion [73- 75].
5. Conclusions
In our previous work, we have shown, that the stiffness of the substrate, changing from 1.5 M Pa to 
600 kPa, significantly affects the behavior of both norm al and IPF-derived lung fibroblasts, indicating 
that elastic moduli of cells m ay play an im portant role in the development of lung fibroblasts also in the 
elasticity range far from the physiological one. This motivated us to expand the study and test in details 
the im pact of substrate stiffness on physicochem ical properties of norm al (LL24) and IPF-derived 
(LL97A) lung fibroblasts. The growth and viability of cells were recorded using fluorescence microscopy 
and M TS tests respectively, for culture tim es ranging from  24 h up to 144 h. For norm al fibroblasts, 
both  fluorescence im aging and M TS tests show  that the num ber of norm al cells is significantly 
reduced on the stiffer substrate. In contrast, for fibrotic fibroblasts, M TS analysis does not reveal 
any rem arkable difference betw een the num ber of IPF-derived cells cultured on stiff and soft PDM S, 
w hereas fluorescence im ages show  a significant variation  of their density. These results indicate 
that substrate elasticity affects the arrangem ent of fibrotic cells rather than their ability to proliferate. 
Additionally, the m easurem ents of elastic m odulus of cells, perform ed using atomic force m icroscopy 
w orking in a force spectroscopy m ode showed that normal fibroblasts remain more rigid as compared 
to their fibrotic counterparts. O bserved difference m ay indicate the im pairm ents of IPF-derived 
fibroblasts induced by the fibrosis process, but it can be also linked w ith  the donor age, different for 
both  cell lines. To resolve this issue, extended studies for patient-derived fibroblasts are required. 
M oreover, elasticity m aps show  that the spatial distribution of m echanical properties differs for both 
examined cell lines. The chemical properties of normal and IPF-derived lung fibroblasts w ere inspected 
using tim e-of-flight secondary ion mass spectrometry (ToF-SIMS), combined with principal com ponent 
analysis (PC A ), w hich  allow s to detect even subtle differences betw een the sam ples. As a result, 
significant differences in the distribution of cholesterol and phospholipids w ere recorded for healthy 
and IPF-derived fibroblasts, w hereas no differences in Ca abundance w ere observed.
The observed different response of both  cell types to the substrate elasticity  suggest that the 
internal structure of cells, modified for fibroblasts for ILD disorders, as w ell as the postulated alteration 
of their mechanical properties influence the cellular behavior and adaptability to the external conditions 
and m ight be therefore be seriously considered as an im portant factor w hile constructing a diagnostic 
tool, enabling the fast and reliable identification of IPF fibroblasts. How ever, before applying such a 
diagnostic tool for a w ide use in m edical laboratories, a special protocol for the collection of cells from 
patients' tissue m ust be developed. A lthough the proposed diagnostic m ethod is not straightforward,
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w e believe that it is w orth  considering, as now adays, there is no fast and reliable diagnostic m ethod 
enabling easy recognition of IPF, w hich is very often misidentified w ith other Interstitial lung diseases 
(ILDs), especially NSIP. Therefore, in our opinion, it seems to be very perspective, as it enables univocal, 
easy, cheap, and relatively fast diagnosis. Even w ith the separate step of cell line derivation from the 
patient's tissue, the diagnostic process should not exceed a few  w eeks, w hich is significantly shorter 
than the current procedures. Moreover, it is based on the analysis of cell stiffness, w hich is a measurable, 
objective param eter, and therefore reduces the possibility of the incorrect interpretation of the results.
Supplementary Materials: The following are available online at http://www.mdpi.com/1996-1944/13/20/4495/s1, 
Figure S1: Intensity of Ca (m/z = 39.96) and CaO (m/z = 56.96) signals recorded using ToF-SIMS for LL24 (blue) and 
LL97 (red) cell line. Error bars indicate the SD (n = 8 ); Figure S2: Ca staining with alizarin red (left part of image) 
and glycosaminoglycans staining with alcian blue (right part of the image) recorded on soft (left column) and stiff 
(central column) PDMS as well as on the control sample (right column) for LL24 (a-c) and LL97A (d-f) cells.
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